title: Transcriptomic "portraits" of canine mammary cancer cell lines with various phenotypes.
abstract: In light of the high incidence of mammary cancer in dogs and completion of the canine genome sequencing, the new possibilities of gene profiling by using DNA microarrays give hope to veterinary oncology. The cell lines isolated from mammary tumors are a valuable tool in developing and testing new pathway-specific cancer therapeutics. Differential cytometric analysis of 6 canine mammary cancer cell lines was performed. We divided cell lines into 3 groups based on their phenotype: 2 lines with high proliferative potential, 2 lines with high antiapoptotic potential, and 2 lines with high metastatic potential. DNA microarray analysis revealed common genes for cell lines of each group. We found that genes encoding the receptors for growth hormone and ghrelin are related to high proliferation rate, while ABR (active BCR-related) and TMD1 (TM2 domain containing 1) genes are related to a high antiapoptotic potential of the cancer cells. Metastatic properties of mammary cancer cells seem to be associated with elevated expression of PGP (P glycoprotein), SEMA3B (semaphorin 3B), and STIM1 (stromal interaction molecule 1).
authors.affiliation: Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Król
authors.forename: K M
authors.initials: KM
authors.lastname: Pawłowski
authors.forename: J
authors.initials: J
authors.lastname: Skierski
authors.forename: P
authors.initials: P
authors.lastname: Turowski
authors.forename: A
authors.initials: A
authors.lastname: Majewska
authors.forename: J
authors.initials: J
authors.lastname: Polańska
authors.forename: M
authors.initials: M
authors.lastname: Ugorski
authors.forename: R E
authors.initials: RE
authors.lastname: Morty
authors.forename: T
authors.initials: T
authors.lastname: Motyl
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000473:pathology / Q000662:veterinary; D000818:Animals; D002455:Cell Division; D045744:Cell Line, Tumor; D004273:DNA, Neoplasm / Q000235:genetics; D004283:Dog Diseases / Q000235:genetics*; D004285:Dogs; D005260:Female; D020869:Gene Expression Profiling; D007700:Kinetics; D015674:Mammary Neoplasms, Animal / Q000235:genetics* / Q000473:pathology; D020411:Oligonucleotide Array Sequence Analysis; D010641:Phenotype; D011003:Ploidies
chemical_list: D004273:DNA, Neoplasm
references.citation: Cancer Res. 2005 Jul 15;65(14):6167-77
references.pmid: 16024618
references.citation: Anim Genet. 2008 Aug;39(4):333-45
references.pmid: 18462483
references.citation: Future Oncol. 2006 Feb;2(1):91-100
references.pmid: 16556076
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4252-7
references.pmid: 15755808
references.citation: In Vitro Cell Dev Biol. 1992 May;28A(5):309-19
references.pmid: 1375928
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
references.pmid: 9843981
references.citation: Leukemia. 2001 Dec;15(12):1823-33
references.pmid: 11753601
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: Anal Biochem. 2006 Sep 1;356(1):36-43
references.pmid: 16844072
references.citation: J Physiol Pharmacol. 2009 May;60 Suppl 1:73-84
references.pmid: 19609016
references.citation: Breast Cancer Res Treat. 2000 Jun;61(3):197-210
references.pmid: 10965996
references.citation: Vet Pathol. 2006 Nov;43(6):934-42
references.pmid: 17099150
references.citation: Nat Genet. 2003 Jan;33(1):49-54
references.pmid: 12469122
references.citation: CA Cancer J Clin. 2002 Jan-Feb;52(1):50-9
references.pmid: 11814065
references.citation: Nature. 2002 Jan 31;415(6871):530-6
references.pmid: 11823860
references.citation: Nucleic Acids Res. 2002 Nov 1;30(21):e116
references.pmid: 12409475
references.citation: J Exp Med. 2008 May 12;205(5):1155-71
references.pmid: 18458115
references.citation: Cancer Res. 1988 Jun 15;48(12):3411-7
references.pmid: 3370639
references.citation: Pol J Vet Sci. 2002;5(1):1-5
references.pmid: 11944580
references.citation: Nature. 2005 Dec 8;438(7069):803-19
references.pmid: 16341006
references.citation: Mol Cancer. 2006 Sep 05;5:34
references.pmid: 16953886
references.citation: Endocr Relat Cancer. 2005 Dec;12(4):839-50
references.pmid: 16322325
references.citation: Nucleic Acids Res. 2005 Jan 1;33(Database issue):D284-8
references.pmid: 15608197
references.citation: J Biol Chem. 2004 Sep 10;279(37):38083-6
references.pmid: 15247279
references.citation: Biostatistics. 2003 Jul;4(3):465-77
references.pmid: 12925512
references.citation: Genome Biol. 2007;8(1):R2
references.pmid: 17204140
references.citation: Genes Dev. 2004 Nov 1;18(21):2581-95
references.pmid: 15520278
references.citation: J Appl Genet. 2010;51(1):37-50
references.pmid: 20145299
references.citation: J Physiol Pharmacol. 2009 May;60 Suppl 1:85-94
references.pmid: 19609017
references.citation: Am J Pathol. 2001 Apr;158(4):1217-22
references.pmid: 11290538
references.citation: J Clin Pharmacol. 2005 Aug;45(8):872-7
references.pmid: 16027397
references.citation: J Physiol Pharmacol. 2009 May;60 Suppl 1:95-106
references.pmid: 19609018
references.citation: Carcinogenesis. 2006 Sep;27(9):1867-75
references.pmid: 16606630